Oral drugs in the HR-positive, HER2-negative metastatic breast cancer space put a focus on clear patient-provider ...
The FDA granted a priority review to acalabrutinib for the treatment of previously untreated adults with mantle cell lymphoma ...
Nurses, Talk AEs, Interstitial Lung Disease, Before Treating With T-DXd ...
Nurses, Talk AEs, Interstitial Lung Disease, Before Treating With T-DXd Non-Operative Management of Rectal Cancer Does Not Worsen Distant RFS ...
The FDA approved neoadjuvant nivolumab plus chemo, followed by adjuvant nivolumab for non-small cell lung cancer without EGFR mutations or ALK rearrangements. The FDA approved neoadjuvant nivolumab ...
Belantamab mafodotin plus KRd had a a manageable safety profile and deep responses in pretreated multiple myeloma. Belantamab mafodotin-blmf (Blenrep) plus carfilzomib, lenalidomide (Revlimid), and ...
Panelists discuss how the current treatment landscape for chronic graft-versus-host disease includes a range of immunosuppressive approaches, from traditional corticosteroids and calcineurin ...
“We [as oncology nurses] end up establishing good rapports with our patients, and we’re basically the frontlines to nutritional deficiencies,” DiRubbo said. “So assessing nutritional needs from the ...
Panelists discuss how physician assistants educate and empower chronic graft-versus-host disease patients and their caregivers to recognize, report, and manage symptoms effectively, detailing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback